SciELO - Scientific Electronic Library Online

 
vol.21 issue6Clinical characteristics of Creutzfeldt-Jakob disease in Mexico: A retrospective analysisThe time of COVID-19: Clinical approaches and research within 2 months of arriving in Mexico author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista mexicana de neurociencia

On-line version ISSN 2604-6180Print version ISSN 1665-5044

Abstract

ESTRADA-BELLMANN, Ingrid  and  MELENDEZ-FLORES, Jesús D.. Ethical implications of shared decision-making in Parkinson’s disease treatment. Rev. mex. neurocienc. [online]. 2020, vol.21, n.6, pp.235-239.  Epub July 30, 2021. ISSN 2604-6180.  https://doi.org/10.24875/rmn.20000022.

Shared decision-making (SDM) involves an active participation of the patient in deciding treatment choice, based on his/her preferences, beliefs, and values. In the context of Parkinson’s disease (PD), physicians encounter limitations in applying this model related to cognitive decline and other disease-related complications. Discussing the ethics of this approach on the context of these limitations the PD patient suffers is thus of great importance. This review intends to analyze ethical challenges of SDM in PD related to decision-making capacity, surrogates’ role in patient’s identity, and patients’ and physicians’ preferences. Although skepticism could arise when dealing with surrogates’ decisions, a key for flourishing the patient’s autonomy is acknowledging its relational context, as relatives’ beliefs and values are imprinted in the patient’s identity. To do so, empathy should be encouraged in physicians, recognizing the different value attribution that patients and their relatives have in the decision process.

Keywords : Cognition; Parkinson disease; Shared decision-making; Surrogate decision maker.

        · abstract in Spanish     · text in English